Search Within

Kylee Maclachlan

Formats
  1. Meeting Abstract (114)
  2. Journal Article (30)
  3. Review (5)
  4. Research Letter (4)
  5. Editorial (2)
Groups
  1. GME, Medicine (155)
  2. Graduate Medical Education (155)
  3. Department of Medicine (135)
  4. Hematologic Malignancies, Division of (131)
  5. Center for Hematologic Malignancies (128)
  6. Myeloma (128)

More Groups

People
  1. Saad Usmani (121)
  2. Alexander Lesokhin (109)
  3. Malin Hultcrantz (101)
  4. Neha Korde (93)
  5. Urvi Shah (92)
  6. Heather Landau (91)

More People

Years
  1. 2025 (4)
  2. 2024 (49)
  3. 2023 (45)
  4. 2022 (31)
  5. 2021 (15)
  6. 2020 (11)
Publications
  1. Blood (70)
  2. Clinical Lymphoma, Myeloma and Leukemia (39)
  3. Journal of Clinical Oncology (7)
  4. Blood Advances (6)
  5. Blood Cancer Journal (6)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. American Society of Hematology (76)
  2. Elsevier Inc. (43)
  3. Nature Publishing Group (12)
  4. American Association for Cancer Research (7)
  5. American Society of Clinical Oncology (7)
  6. Royal College of Pathologists of Australasia (1)

More Publishers

Results (155)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The complex structural variant chromothripsis can be defined on targeted sequencing panels, allowing direct clinical translation in order to improve multiple myeloma prognostication
    Meeting Abstract

    Maclachlan, K. H.; Ziccheddu, B.; Tan, C.; Shekarkhand, T.; Rueda, C.; Serrano, E.; Diamond, B.; Hassoun, H.; Mailankody, S.; Shah, U. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Identifying causes of unscheduled healthcare interactions and changes to patient disposition in individuals receiving outpatient commercial bispecific antibody therapy in relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Howard, A. J.; Shekarkhand, T.; Hamadeh, I. S.; Wang, A.; Patel, D.; Tan, C.; Hultcrantz, M.; Mailankody, S.; Hassoun, H.; Shah, U. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A whole foods plant-based weight loss intervention improves quality of life, metabolic, microbiome and immune profile in MGUS/SMM as well as progression trajectory in a subset - the Nutrivention trial
    Meeting Abstract

    Shah, U. A.; Castro, F.; Derkach, A.; Fei, T.; Hosszu, K. K.; McAvoy, D.; DeWolf, S.; Cross, J.; Gradissimo, A.; Nwankwo, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Genomic and transcriptomic landscape of hyper-APOBEC multiple myeloma
    Meeting Abstract

    Papadimitriou, M.; Tauro, M.; Ziccheddu, B.; Poos, A. M.; Alaoui, A. Y.; Meads, M. B.; Maclachlan, K. H.; Usmani, S. Z.; Raab, M. S.; Morgan, G. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Somatic hypermutation in enhancer regions shapes non-coding myeloma genome, generating DNA breaks and driving etiology through mutation and structural variation
    Meeting Abstract

    Blaney, P.; Walker, B. A.; Mikulasova, A.; Gagler, D.; Ziccheddu, B.; Diamond, B.; Wang, Y.; Hou, L.; Liu, S.; Poos, A. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Genomic profiling to interpret the outcomes of early intervention for high-risk smoldering myeloma
    Meeting Abstract

    Diamond, B.; Kazandjian, D.; Papadimitriou, M.; Ziccheddu, B.; Blaney, P.; Chojnacka, M.; Durante, M.; Hill, E.; Sklavenitis-Pistofidis, R.; Maclachlan, K. H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The temporal evolution of chromosome 1q gain and hyperdiploidy and its impact on clinical outcomes in multiple myeloma
    Meeting Abstract

    Maura, F.; Kaddoura, M.; Poos, A. M.; Cirrincione, A.; Diamond, B.; Maclachlan, K. H.; Ziccheddu, B.; Mai, E. K.; Goldschmidt, H.; Weisel, K.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Revealing novel mechanisms underlying inactivation of tumor suppressor genes on duplicated chromosomes in multiple myeloma
    Meeting Abstract

    Cirrincione, A.; Kaddoura, M.; Poos, A. M.; Ziccheddu, B.; Maclachlan, K. H.; Chojnacka, M.; Diamond, B.; Blaney, P.; Gagler, D.; Zhang, Y.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Carfilzomib,lenalidomide and dexamethasone (KRd) as induction therapy in high-risk newly diagnosed multiple myeloma
    Meeting Abstract

    Tan, C.; Korde, N.; Derkach, A.; Hultcrantz, M.; Maclachlan, K. H.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Patel, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
    Meeting Abstract

    Hamadeh, I. S.; Shekarkhand, T.; Rueda, C.; Firestone, R.; Wang, A.; Korde, N.; Hultcrantz, M.; Lesokhin, A.; Mailankody, S.; Hassoun, H.; more...
    Blood (2023)

    Fulltext@MSK | Save